Source comparison
MK-677 Injection Sites: Administration Route Comparison
| Route | Site | Needle Specs | Absorption Profile | Peak Plasma (Cmax) | Variance Risk | Best Use Case ||—|—|—|—|—|—|| Subcutaneous | Abdominal (2–3 inches lateral to navel) | 25–27G, 0.5-inch | Gradual diffusion through adipose depot | 90–120 min | Low. Cons
This comparison does not assign a generated winner or score.
- | Route | Site | Needle Specs | Absorption Profile | Peak Plasma (Cmax) | Variance Risk | Best Use Case ||—|—|—|—|—|—|| Subcutaneous | Abdominal (2–3 inches lateral to navel) | 25–27G, 0.5-inch | Gradual diffusion through adipose depot | 90–120 min | Low. Consistent across subjects | Protocols requiring tight PK control, multi-week dosing || Intramuscular | Deltoid | 21–23G, 1-inch | Rapid uptake via muscle capillaries | 45–60 min | Moderate. Site-dependent blood flow | Single-dose studies, acute response measurement || Intramuscular | Ventrogluteal | 21–23G, 1.5-inch | Moderate uptake, deep muscle depot | 60–75 min | Moderate. Technique-dependent depth | High-volume injections (>1.5 mL), reduced nerve risk || Intramuscular | Vastus Lateralis | 21–23G, 1.5-inch | Variable uptake based on muscle mass | 50–70 min | High. Subject variability in thigh adiposity | Alternative when other IM sites unavailable |